Alcon (SIX/NYSE: ALC), the global leader in eye care, will host its 2025 Capital Markets Day on March 27, 2025, beginning at ...

Terry Kim, MD, is a board-certified ophthalmologist, Chief Medical Officer at Alcon, and Professor of Ophthalmology at Duke ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, proudly announces the opening of the Alcon ...

ALC's performance is driven by robust demand for its innovative products, balanced geographic footprint and strong execution by the team.

On an installed base, Alcon is the number-one player in phacoemulsification machines (used to remove cataracts), vitrectomy machines, and refractive lasers. We expect the segment to grow in ...

a next generation phacoemulsification-vitreoretinal cataract system, Unity DX, a new diagnostic device, and AR-15512, a dry eye drug. We are particularly excited about Unity VCS since Alcon has a ...

3 “Alcon is dedicated to developing treatments ... people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors.

Alcon, Inc. ALC delivered fourth-quarter 2024 ... Consumables net sales increased 7% at CER, driven by vitreoretinal and cataract consumables and price increases. Our model projected a growth ...

Furthermore, central corneal thickness (CCT) was measured by ultrasound pachymetry using the Ocuscan® R x P Alcon®. After the preoperative examination, patients were randomized into two groups ...

and has given talks for Alcon. Patients after cataract surgery at the Project Vision Center in Sanrao.